The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDC..L Regulatory News (DC.)

  • There is currently no data for DC.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2019 AGM Results - update statement

20 Feb 2020 09:08

RNS Number : 5966D
Dixons Carphone PLC
20 February 2020
 

20 February 2020

 

DIXONS CARPHONE PLC

 

Further statement in relation to AGM vote on Directors' Remuneration Report

 

The Board of Dixons Carphone plc (the "Company") welcomed the 76.54% vote in favour of the 2018/19 Remuneration Report at the Annual General Meeting ("AGM") held on 5 September 2019 although acknowledge that a significant minority of shareholders did not support this resolution.

 

In addition, the Board welcomed the support received from most of the Company's largest shareholders and the 89.26% vote in favour of the Remuneration Policy.

 

The Company explained in its AGM Results announcement the action it intended to take to understand and address shareholder concerns about the Remuneration Report and an update is provided below.

 

Since the AGM, the Company has sought further engagement with our shareholders and the proxy agencies to discuss the specific rationale for the votes against our Remuneration Report. As part of this engagement, the Company has either met with, or written to, shareholders representing over 70% of the Company's share capital and invited them to attend meetings with their choice of the Group Chairman, Chair of the Remuneration Committee or Chair of the Audit Committee. In addition, the Company commissioned a voting analysis report to identify those shareholders that had opposed resolutions at the AGM. Additional engagement requests have been sent to those shareholders that did not support the Remuneration Report but had also not accepted the Company's offer to meet.

 

The concerns expressed by those shareholders and shareholder advisers that have provided feedback related to:

·; the level of bonus payments for 2018/19 given the assessment of business performance; and

·; the number of shares in the 2019 LTIP award given the lower share price.

 

In the context of the concerns raised, the Remuneration Committee recognises that 2018/19 remuneration was a difficult judgement at this point in the business transformation. The Group Chief Executive and Group Chief Financial Officer joined the business in April 2018 and August 2018 respectively and delivered the financial targets for 2018/19 in line with the Company's guidance issued in 2018.

 

In addition, the Group Chief Executive and Group Chief Financial Officer both deferred 100% of their cash bonus for 2018/19 into share awards that will not vest for 2 years. The executives volunteered to do this as they were mindful that the performance of the business and the progress that is being made with the transformation had not been reflected in the Company's share price and wanted to align themselves with shareholders.

 

Finally, the Company did reduce the allocation of LTIP shares from 275% to 250% of salary one year ahead of the implementation of the new Remuneration Policy.

 

The Company continues to believe that the 2018/19 Remuneration Report and Policy were appropriate in the context of incentivising a new management team embarking on a major transformation of the business.

 

The Company's Remuneration Committee and the Board have welcomed the opportunity to have constructive discussions on remuneration with our shareholders. The Remuneration Committee will consider the feedback received during this process when assessing future performance and awards.

 

The Company will provide a final update in the 2019/20 Annual Report and Accounts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMFIFIAFEIIFII
Date   Source Headline
15th Sep 20211:16 pmRNSChange of Name
15th Sep 202111:22 amRNSResult of AGM
1st Sep 202110:35 amRNSTotal Voting Rights
19th Aug 202112:08 pmRNSDirector/PDMR Shareholding
2nd Aug 20215:00 pmRNSDirector/PDMR Shareholding
2nd Aug 202111:22 amRNSTotal Voting Rights
28th Jul 202110:58 amRNSAnnual Financial Report
23rd Jul 202111:14 amRNSDirector/PDMR Shareholding
21st Jul 20214:04 pmRNSDirector/PDMR Shareholding
21st Jul 20212:38 pmRNSDirector/PDMR Shareholding
13th Jul 20219:45 amRNSHolding(s) in Company
7th Jul 20214:05 pmRNSDirector Declaration
6th Jul 202112:30 pmRNSAmended: Director/PDMR Shareholding
6th Jul 202110:30 amRNSDirector/PDMR Shareholding
1st Jul 20219:55 amRNSTotal Voting Rights
30th Jun 20215:06 pmRNSDividend Declaration
30th Jun 20217:00 amRNSFinal Results
25th Jun 20211:00 pmRNSHoldings in Comapany
10th Jun 20219:00 amRNSDirector Declaration
1st Jun 20211:36 pmRNSTotal Voting Rights
13th May 202110:00 amRNSDixons Carphone plc to become Currys plc
4th May 20213:07 pmRNSTotal Voting Rights
28th Apr 20217:00 amRNSPre-close Trading Update
8th Apr 202112:00 pmRNSDirector/PDMR Shareholding
1st Apr 202111:15 amRNSTotal Voting Rights
2nd Mar 20219:52 amRNSTotal Voting Rights
16th Feb 202110:11 amRNSHolding(s) in Company
2nd Feb 202111:38 amRNSTotal Voting Rights
20th Jan 20217:00 amRNSAppointment of new Group Chief Financial Officer
20th Jan 20217:00 amRNSPeak Trading Statement - 2020/21
13th Jan 20213:58 pmRNSHolding(s) in Company
4th Jan 20214:55 pmRNSTotal Voting Rights
16th Dec 20207:00 amRNSInterim Results 2020/21
1st Dec 202011:35 amRNSTotal Voting Rights
2nd Nov 20201:42 pmRNSHolding(s) in Company
2nd Nov 20201:27 pmRNSTotal Voting Rights
9th Oct 20201:48 pmRNSHolding(s) in Company
5th Oct 20205:35 pmRNSHolding(s) in Company
1st Oct 20203:08 pmRNSTotal Voting Rights
30th Sep 20203:15 pmRNSDirector Declaration
24th Sep 20201:24 pmRNSHolding(s) in Company
10th Sep 20203:37 pmRNSResult of AGM
10th Sep 20207:00 amRNSAGM Trading Statement 2020/21
1st Sep 20202:52 pmRNSTotal Voting Rights
1st Sep 20202:48 pmRNSDirector/PDMR Shareholding
20th Aug 202010:00 amRNSDirector/PDMR Shareholding
3rd Aug 20209:15 amRNSTotal Voting Rights
28th Jul 202012:07 pmRNSAnnual Financial Report
27th Jul 20202:12 pmRNSHolding(s) in Company
15th Jul 20207:00 amRNSFinal Results 2019/20

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.